263 results on '"Tyrosine -- Genetic aspects"'
Search Results
2. STAT5B leukemic mutations, altering SH2 tyrosine 665, have opposing impacts on immune gene programs
3. Radboud University Nijmegen Medical Centre Researchers Release New Data on Receptor Protein-Tyrosine Kinases (A rare homozygous INS variant causes adult-onset diabetes)
4. Study Findings on Tyrosine Kinase Inhibitors Are Outlined in Reports from Dartmouth-Hitchcock Medical Center (An Inflammatory Myofibroblastic Tumor With a Novel alkv1180l Mutation Leading To Acquired Resistance T
5. Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning (Updated December 5, 2024)
6. Research from CHA Advanced Research Institute Has Provided New Data on Cancer (In vitro effectiveness of CB469, a MET tyrosine kinase inhibitor in MET-activated cancer cells)
7. Reports Summarize Chronic Myeloid Leukemia Research from Chinese University of Hong Kong (PBA2, a novel inhibitor of the b-catenin/CBP pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation)
8. New Thyroid Cancer Data Have Been Reported by Investigators at University of Pennsylvania (tg-igf1r: a Novel Receptor Tyrosine Kinase Fusion Oncogene In Pediatric Thyroid Cancer)
9. Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning
10. Data on Anaplastic Large Cell Lymphoma Reported by Researchers at Dana-Farber Cancer Institute (Stat3 Couples Activated Tyrosine Kinase Signaling To the Oncogenic Core Transcriptional Regulatory Circuitry of Anaplastic Large Cell Lymphoma)
11. Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain. (Updated May 7, 2024)
12. Research Reports from University of Lille Provide New Insights into Cancer (Recording and classifying MET receptor mutations in cancers)
13. Affiliated Hospital of Southwest Medical University Researchers Update Knowledge of Tyrosine Kinase Inhibitors (Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy)
14. ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis
15. Studies in the Area of Antineoplastics Reported from Hainan Medical University (Biphasic Function of Gsk3b In Gefitinib-resistant Nsclc With or Without Egfr Mutations)
16. Anticancer Agent 'TASFYGO Tablets 35mg' (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
17. E41K Mutation Activates Brutons Tyrosine Kinase by Stabilizing an Inositol Hexakisphosphate Dependent Invisible Dimer
18. Data from Kobe University Graduate School of Medicine Update Knowledge in Lung Cancer (HIP1-ALK-Rearranged Lung Cancer in a Young Adult With BRAF V600E Mutation Detected After ALK Tyrosine Kinase Inhibitor Therapy: A Case Report)
19. Clustering of colon, lung, and other cancer susceptibility genes with protein tyrosine phosphates and protein kinases in short genomic segments
20. European Institute of Oncology IRCCS Researcher Furthers Understanding of Amino Acids (New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations)
21. National Eye Institute Researchers Broaden Understanding of Molecular Science (Human gS-Crystallin Mutation F10_Y11delinsLN in the First Greek Key Pair Destabilizes and Impairs Tight Packing Causing Cortical Lamellar Cataract)
22. Studies in the Area of Cancer Reported from Lehigh University (Promoting the Activity of a Receptor Tyrosine Phosphatase With a Novel Ph-responsive Transmembrane Agonist Inhibits Cancer-associated Phenotypes)
23. Data on Kinase Inhibitors Detailed by Researchers at University of South Florida Morsani (The broad spectrum of tyrosine kinase inhibitors. Treatment of a rare R776H mutation with Osimertinib: Case report)
24. Study Results from University of Texas MD Anderson Cancer Center Update Understanding of Acute Lymphoblastic Leukemia (Ponatinib Vs Imatinib In Frontline Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia)
25. Compound Mutations in the Abl1 Kinase Cause Inhibitor Resistance by Shifting DFG Flip Mechanisms and Relative State Populations
26. Detection of EGFR T790M Mutation by Droplet Digital Polymerase Chain Reaction in Lung Carcinoma Cytology Samples
27. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors
28. Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumors
29. Targeting AML-associated FLT3 mutations with a type I kinase inhibitor
30. Differential expression of RET tyrosine kinase in cancers of the breast. (Updated February 6, 2023)
31. Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
32. INESC TEC-Institute for Systems and Computer Engineering Researchers Update Current Data on Receptor Protein-Tyrosine Kinases (Semi-Supervised Approach for EGFR Mutation Prediction on CT Images)
33. Universidad Autonoma de Guadalajara Researchers Yield New Data on Adenocarcinoma [Delving into the Role of Receptor-like Tyrosine Kinase (RYK) in Cancer: In Silico Insights into Its Diagnostic and Prognostic Utility]
34. SIEMBRASUR S A secures contract for SURGICAL INTERVENTION AND ANALYSIS Item NA¦25 Mutation Determination in Jak2 kinase tyrosine gene (Janus Activated Kinase) (Code of Article 42987)
35. Findings from University of British Columbia Reveals New Findings on Nerve Tissue Proteins [Novel Pathogenic Variants In Tubulin Tyrosine Like 5 (ttll5) Associated With Cone-dominant Retinal Dystrophies and an Abnormal Optical Coherenc
36. Reports on BCR-ABL Tyrosine Kinase Inhibitors Findings from National Institute of Blood Diseases & Bone Marrow Transplantation Provide New Insights (Influence of cytochrome P450 and glutathione S transferase polymorphisms on response to ...)
37. iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation
38. Researchers at Department of Oncology Release New Data on Lung Cancer (Case Report: Egfr-mutant Lung Adenocarcinoma With the Tp53 and Rb1 Mutations Showed Resistance To Tki Therapy)
39. Study Results from Ontario Institute for Cancer Research Broaden Understanding of Lung Cancer (Chemical Genetics Screen Identifies Copb2 Tool Compounds That Alters Er Stress Response and Induces Rtk Dysregulation In Lung Cancer Cells)
40. New Acute Lymphoblastic Leukemia Data Have Been Reported by Researchers at Okayama University Hospital (A Boy Safely Treated With Tyrosine Kinase Inhibitors for Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia With Osteolysis)
41. Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency
42. Study Results from Department of Medical Oncology Broaden Understanding of Kinase Inhibitors (Which Tyrosine Kinase Inhibitor Must We Apply Before? a Case Report of Crizotinib-resistant Patient With Concomitant Egfr and Eml4-alk Gene Mutations)
43. Study Findings from University of Bologna Update Knowledge in Acute Myeloid Leukemia (Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia)
44. Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH
45. Researchers from Sun Yat-sen University Detail New Studies and Findings in the Area of Lung Cancer (A Rapid and Durable Response To Cabozantinib In an Osimertinib- Resistant Lung Cancer Patient With Met D1228n Mutation: a Case Report)
46. Differential expression of tubulin tyrosine ligase-like 7 in human epithelial ovarian cancer
47. Epidermal growth factor receptor mutated lung cancers: Looking beyond adenocarcinomas
48. S BIDEGAIN S A secures contract for Item Studies NA¦1 Professional Timbre (Code Article 10233) Item NA¦2 Mutation Determination in Jak2 kinase tyrosine gene (Janus Activated Kinase) (Code Article 42987)
49. New Receptor Protein-Tyrosine Kinases Study Findings Recently Were Published by Researchers at Lishui Hospital of Zhejiang University (Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin ...)
50. Differential expression of protein tyrosine phosphatase, non-receptor type 6 in human epithelial ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.